All News #Library
Biotech
ENHERTU Launches Adjuvant Phase 3 Trial in HER2+ Endometrial
22 Dec 2025 //
BUSINESSWIRE
Destiny ends COVID collab, Santhera returns lonodelestat
25 Apr 2024 //
FIERCE BIOTECH
UK biotech hands off mid-stage C. difficile drug in up to $570M deal
27 Feb 2023 //
ENDPTS

Market Place
Sourcing Support